Arterial Chemoembolisation With Cisplatin vs Epirubicin for Hepatocellular Carcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Arterial chemoembolisation with cisplatin versus epirubicin for hepatocellular carcinoma (ACE 500 study): A multicentre, randomised controlled phase 2/3 trial
Eur. J. Cancer 2021 Sep 23;157(xx)373-382, O Aramaki, T Takayama, M Moriguchi, H Sakamoto, H Yodono, N Kokudo, N Yamanaka, S Kawasaki, Y Sasaki, K Kubota, E Otsuji, S Tanaka, Y Matsuyama, M FujiiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.